Hyponatremia as an Inflammatory Marker of Lupus Activity Is a Fact or Fad: A Cross-Sectional Study
Ahmed Yamany, Mervat E Behiry, Sahar A Ahmed Faculty of Medicine, Cairo University, Cairo, EgyptCorrespondence: Mervat E Behiry Tel +20 1124205071Fax +20 26 28 884Email lambaa2020@yahoo.comPurpose: Systemic lupus erythematosus (SLE) is an autoimmune disease with multi-organ involvement. Hyponatremia...
Guardado en:
Autores principales: | Yamany A, Behiry ME, Ahmed SA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/464f5877807f4f5b9936984fb90ca218 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Systemic Lupus Erythematosus and Myasthenia Gravis in a Male Patient: an HLA Case Investigated
por: Eleni Klimi, et al.
Publicado: (2021) -
Correlation Between Steroid Therapy and Lipid Profile in Systemic Lupus Erythematosus Patients
por: Atik N, et al.
Publicado: (2020) -
Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies
por: Tselios K, et al.
Publicado: (2016) -
Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: an alternative to standard of care
por: Chessa E, et al.
Publicado: (2017) -
Management of systemic lupus erythematosus during pregnancy: challenges and solutions
por: Knight CL, et al.
Publicado: (2017)